CHATHAM, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

PharmaJet needle-free delivery enhances immune response and provides safety, efficacy, efficiency, and patient comfort for ...

Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset——Joint poster presentation with Bachem to ...

05, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and ...

Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders ...

Research projects by Cameron University chemistry students were among the 250 undergraduate oral and poster presentations featured at the recent American Chemical Society Southwest Regional Meeting in ...

Undergraduate students from all disciplines are invited to submit a research abstract to the U of A's Undergraduate Research Week Poster Competition. Submissions are due by Jan. 21, 2025.

Imvax, Inc. today announced an oral presentation and two poster presentations at the 2024 SNO Annual Meeting in Houston, Texas.

Poster presentations across all programs, including updates from ongoing clinical studies and new translational data in preclinical models supporting use in existing and additional indications ...

This study was not peer-reviewed, however. Rather, it was a poster shown at the American Thyroid Association’s Annual Meeting ...

Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.